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Abstract
Background: This study aimed to examine whether fear of cancer recurrence (FCR) was related to two
important health behaviours (physical activity and smoking) in a large sample of colorectal cancer
patients.
Methods: Ten thousand nine hundred sixty nine patients, diagnosed in 2010–11, and in remission in
2013, completed the ‘Living with and Beyond Colorectal Cancer’ survey. The survey included
purpose-designed questions on fear of recurrence (‘I have fear about my cancer coming back’), demo-
graphics, treatment and health variables. Physical activity (PA) was recorded as number of days per
week doing at least 30 min of brisk activity, and smoking status was reported.
Results: Fifty per cent of respondents reported fear of their cancer returning. More women than
men ((Odds Ratio; (OR) 1.58; 95% confidence interval (CI) 1.46, 1.71)) more younger than older patients
(OR 2.53; CI 2.33, 2.74) and slightly more patients from deprived areas (OR 1.14, 1.05, 1.23) reported
FCR. Independently of demographics and treatment, compared with those meeting the PA guidelines,
those who were doing only ‘some’ (OR 1.22; CI 1.11, 1.35) or ‘no’ PA (OR 1.28; CI 1.15, 1.42) reported
higher FCR. Compared with non-smokers, more current smokers reported fear (OR 1.34, CI 1.10, 1.58)
and slightly more ex-smokers (OR 1.11; CI 1.04, 1.21).
Conclusions: This cross-sectional study provided novel data showing that colorectal cancer survi-
vors with poorer health behaviours (those with lower activity levels and those who smoked) were more
likely to experience FCR. Future research should replicate findings using detailed measures of fear,
objective measures of health behaviours and identify directions of associations.
© 2016 The Authors. Psycho-Oncology Published by John Wiley & Sons Ltd.
Introduction
Colorectal cancer is the fourth most common cancer in the
UK, with around 40 000 new cases each year [1]. Earlier
diagnosis and improvement in treatments mean that 5-year
and 10-year survival rates are now greater than 50% [2],
so there is a focus on ensuring the best possible quality
of life following diagnosis. Treatment of colorectal cancer
usually involves surgical removal of the tumour, often with
chemotherapy or radiotherapy. If the cancer returns follow-
ing successful initial treatment, this is termed ‘cancer recur-
rence’ [3]. The existing literature suggests that a significant
proportion of cancer survivors suffer fear and anxiety that
may substantially impair quality of life, even past 5-year
survival [4,5]. Indeed, fear of cancer recurrence (FCR) is
commonly reported by survivors to be one of the most com-
mon unmet rehabilitation needs in their care pathway [6,7].
There is emerging evidence that practising healthful be-
haviours (particularly being sufficiently physically active
and not smoking) following a diagnosis of colorectal
cancer may reduce the risk of recurrence. In a meta-
analysis of six prospective cohort studies examining
post-diagnosis physical activity, those who reported
higher levels of physical activity following a diagnosis
of colorectal cancer had significantly reduced risk of
cancer-specific mortality [8]. A systematic review and
meta-analysis of 16 studies found that current smoking
(and to a lesser extent former smoking) were associated
with poorer prognosis [9]. Given that FCR seems to be a
key issue for people living with and beyond colorectal
cancer, patients might be expected to make positive life-
style changes. A number of theoretical models of health
behaviour change, such as the Protection Motivation The-
ory and the Extended Parallel Processing Model, posit that
perceptions of vulnerability to a health threat may moti-
vate protective health behaviours [10,11]. However, there
is little evidence that a cancer diagnosis alone acts a trig-
ger for positive health behaviour change; a significant pro-
portion of cancer survivors are insufficiently active,
overweight and high-risk drinkers, although a relatively
low proportion report being smokers [12,13]. This sug-
gests that patients need support in making lifestyle
changes. Understanding the factors that relate to lifestyle
and to FCR in colorectal cancer is an important step in de-
signing comprehensive lifestyle interventions.
Most literature has focused on demographic factors re-
lating to FCR (mainly in breast, head and neck, and pros-
tate cancer survivors), generally demonstrating that fear is
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higher in women than men and higher in younger than
older patients (reviewed in 14). Treatment types have been
related to FRC, but findings are less consistent, probably
reflecting the varying cancers studied [14]. However, very
few studies have examined associations between health
behaviours and FCR in any group of cancer survivors.
In a repeat measures study of 73 patients with oral or
oropharyngeal cancer, past and current tobacco use were
associated with higher levels of psychological distress,
and smokers reported higher FCR [15]. In a longitudinal
study of 154 thoracic or head and neck cancer patients,
higher baseline FCR was associated with greater likeli-
hood of continuing smoking [16]. One study in 218 early
stage breast cancer patients reported that higher fear was
associated with higher frequency of GP visits, self-
examination and use of more counselling and support
groups, but diet, physical activity, smoking or alcohol
were not considered [17]. A cross-sectional study in
1336 long term survivors of testicular cancer also found
smokers were more likely to experience FCR, but there
was no association between fear and physical activity or
alcohol consumption [18]. In a cross-sectional study of
7903 participants in the American Cancer Society’s Study
of Cancer Survivors II (mixed diagnoses, but the majority
breast and prostate), FCR was positively correlated with a
composite score of self-rated positive health behaviour
changes [19]. To our knowledge, no quantitative studies
have specifically examined the factors associated with
FCR in survivors of colorectal cancer.
Therefore, the aims of this study were to use the largest
existing relevant dataset of colorectal cancer patients to ex-
amine associations between FCR two important health be-
haviours. Associations between fear and socio-demographic
and treatment factors were also explored.
Methods
Procedure
Data were from the Living with and Beyond Colorectal
Cancer survey, commissioned by the UK Department of
Health in 2013 as part of a programme of work designed
to ensure that UK cancer patients’ needs are met across
a range of health, psychosocial and lifestyle domains,
through recording patient reported outcomes (PROMS)
[20]. The questionnaire was mailed by the National
Cancer Registration Service (NCRS) to adult patients with
a recorded diagnosis of colorectal cancer in 2010 or 2011
from hospitals around England and Wales (n=34 467
were eligible). Permission to approach patients was
granted to NCRS by the National Information Governance
Board [ref ECC 5-02(FT8)/12] and patients consented by
returning completed questionnaires. Authors of the current
study applied formally to NCRS for permission to perform
secondary analyses on health and lifestyle data from the
PROMS. Data were provided fully anonymised and au-
thors had no access to any patient-identifiable data. The
current study was reviewed by NCRS and University
College London, and in line with the University College
London Ethics Committee, additional ethical approval was
not required for secondary analyses of anonymous survey
data. Content and face validity for the PROMS survey were
identified through expert review and consultation with pa-
tients, experts and charity advisory groups [21].
Measures
Fear of cancer recurrence
The questionnaire section ‘Your Health and Wellbeing in
the Past Month’ included the single-item purpose-
designed question ‘I have fear about my cancer coming
back’ (‘fear of recurrence’) with responses on a 5 point
Likert scale (strongly disagree/disagree/neither agree or
disagree/agree/strongly agree: coded 1–5) or ‘does not ap-
ply to me’ (coded as missing for the current study). The
Living with and Beyond CRC survey was developed to
audit multi-dimensional aspects of care with a focus on
quality of life and function. The current study involved
secondary analyses of existing data, and a validated scale
of FCR was not included in the survey because FCR and
lifestyle were not a primary focus. However, the data gath-
ered provide a unique opportunity to capture the views
and behaviours of an extremely large and representative
sample of CRC survivors. Additionally, much of the liter-
ature on FCR has used single-item assessments of FCR,
and findings are in accordance with more detailed vali-
dated scales (reviewed in [14]).
Health behaviours
Current physical activity was assessed by asking ‘In the
past week how many days have you done 30 minutes or
more of brisk physical activity (This may include sport, ex-
ercise or brisk walking or cycling for recreation or to get
to and from places, but should not include housework that
or physical activity that is part of your job)’. Responses
were number of days from 0–7. Activity categories were
‘meeting guidelines’ (≥5 days per week), ‘some’ (1–4 days)
and none (0 days). Smoking status was assessed using the
question ‘Do you consider yourself to be a smoker/ ex-
smoker / non-smoker?’.
Demographics, treatment and health
Potential socio-demographic and treatment confounders
were selected a priori based on the existing literature on
factors associated with FCR [14]. Sex, age at diagnosis
and ethnicity were recorded by patients. Socioeconomic
status based on the Index of Multiple Deprivation score
for home postcode was provided by the NCRS. Treatment
questions included in the current study were ‘How has
A. Fisher et al.
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your CRC responded to treatment’ (‘fully responded I am
in remission’, ‘has been treated but is still present’, ‘has
not been treated’, ‘has come back after initial treatment’,
‘not certain what is happening’). Length of time since
treatment was also assessed. Comorbidities were assessed
with ‘Do you have a long-standing health condition other
than cancer’ (‘yes’, ‘no’, ‘can’t say’). Virtually all pa-
tients reported having had surgery; however, in addition,
they were asked to record whether they had received che-
motherapy or radiotherapy.
Analyses
For ease of interpretation, for main analyses, FCR data scores
were categorised to those reporting no fear (categories 1–3)
or reporting fear (categories 4–5). These analyses were re-
peated excluding category 3 (‘neither agree nor disagree’).
However, because results did not change, these patients were
included, giving approximately equal-sized groups. Binary
logistic regressions (fear/no fear as the outcome) were carried
out, and simple associations were presented between demo-
graphics, health behaviours and treatment and health vari-
ables and fear presented. Adjusted models were also run for
all demographics, both health behaviours adjusting for demo-
graphics, treatment and health and treatment and health
adjusting for demographics. To illustrate the magnitude of
the effect for health behaviours, graphs were also presented
with FCR as a continuous outcome, using data analyses of
covariance with polynomial contrasts.
Results
The overall response rate to the survey was 63.3%, re-
ported by Downing et al. [22]. In the lifestyle dataset pro-
vided for the current study, 17 753 surveys were at least
partially completed. Non-responders were more likely to
be from more deprived residential areas and more likely
to be from the youngest and oldest age categories than
non-responders (p<0.001). Ethnicity of non-responders
was not available for comparison, as this was gathered
from the survey. Two hundred three participants who re-
ported having Alzheimer’s or dementia were excluded
(because the questionnaire relied on participant recall)
and only those patients who reported being in remission
were included (n=12,933). Of those, 602 (4.9%) recorded
that FCR ‘did not apply to them’ (reasons for reporting
this were not reported), leaving 11 686 patients. Ten thou-
sand nine hundred sixty nine patients had complete data
on all key outcomes for the current study.
Sample characteristics are presented in Table 1. 61% of
the sample were men, 97% were white and 62% were ≥65
years old. Half of the patients (50%) reported some fear of
their cancer returning. Twenty-three per cent of patients
met the guidelines for physical activity, 47% reported do-
ing 1–4 days per week and 30% reported doing none. Five
per cent were smokers, 40% ex-smokers and 55% non-
smokers.
Factors associated with FCR are shown in Table 1.
More women than men, more younger than older patients,
and slightly more patients from deprived areas reported
fear (p<0.001). Associations with ethnicity could not be
assessed because only 338 patients were from a non-white
ethnic group and of those, 182 classified themselves only
as ‘other’. All significant associations between demo-
graphics and FCR remained in adjusted models. Treat-
ment factors were related to FCR; patients who had
more recently completed treatment were more likely to re-
port fear (p<0.001). In simple models, patients who re-
ceived chemotherapy or radiotherapy were more likely
to report fear (p<0.001). However in adjusted models,
only chemotherapy was significant.
Associations between FCR and health behaviours are
also shown in Table 1. After adjustment for multiple de-
mographic and treatment confounders, when compared
with those meeting the PA guidelines, patients who were
doing some ((Odds Ratio (OR) 1.22, 95% Confidence In-
terval (CI) 1.11, 1.35, p<0.001)) or no physical activity
(OR 1.28, CI 1.15, 1.42 p<0.001) reported higher levels
of fear. When compared with never smokers, current
smokers reported higher levels of fear (OR 1.34, CI 1.10,
1.58, p<0.005), and ex-smokers reported slightly higher
levels (OR 1.11, CI 1.04, 1.21, p<0.005). Figure 1 illus-
trates the continuous associations between physical activity
level and FCR. There was a significant linear trend for
higher levels of fear with lower levels of activity. Similarly,
as shown in Figure 2, there was a significant association be-
tween smoking and FCR, such that fear was highest in cur-
rent, then ex-smokers then non-smokers.
Discussion
This was the first study to explore whether health
behaviours related to FCR in colorectal cancer patients.
We found that those with lower levels of PA, and current
smokers, were more likely to experience FCR although
the magnitude of those associations was relatively small.
Additionally, this study adds to the literature demonstrat-
ing that demographic and treatment factors are related to
fear.
In our study, current smokers (compared with never or
ex-smokers) were more likely to report fear. Although
no studies in colorectal cancer survivors have previously
examined associations between FCR and smoking status,
comparable literature comes from head and neck cancer pa-
tients, where it has been observed that smokers report signif-
icantly higher levels of fear [15]. It is plausible that the links
between smoking and cancer are so widely publicised, and
iterated by health professionals during the care pathway
for patients undergoing curative treatment, that those who
smoke have higher FCR. However, in a longitudinal study
FCR and CRC
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Table 1. Demographics, health behaviours and treatment associations with fear of cancer recurrence in 10 969 colorectal cancer patients
% Unadjusted OR (95% CI) Adjusted OR (95% CI)
n
Demographics (A)
Sex
Male 3081 61.1 1 1
Female 4264 38.9 1.59 (1.48, 1.72)*** 1.58 (1.46, 1.71)***
Age
≥65 6772 61.7 1 1
<65 4197 38.3 2.53 (2.33, 2.74)*** 2.52 (2.32, 2.73)***
SES
Lower (less deprived) 5813 53.0 1 1
Higher (more deprived) 5156 47.0 1.14 (1.06, 1.23)*** 1.14 (1.05, 1.23)***
Health behaviours (B)
Physical activity
Meeting guidelines 2495 22.7 1 1
Some 5159 47.0 1.26 (1.13, 1.39)*** 1.22 (1.11, 1.35)***
None 3315 30.2 1.29 (1.17, 1.42)*** 1.28 (1.15, 1.42)***
Smoking
Non-smoker 5978 54.5 1
Ex-smoker 4418 40.3 1.03 (0.95, 1.11) 1.11 (1.04, 1.21)**
Current smoker 573 5.2 1.44 (1.21, 1.72)*** 1.34 (1.10, 1.58)**
Treatment (C)
Time since treatment
≥1 year 9574 12.1 1 1
<1 year 1314 87.9 1.47 (1.31, 1.66)*** 1.26 (1.11, 1.43)***
Unknown/missing 81
Radiotherapy
No 8882 81.4 1 1
Yes 2027 18.6 1.25 (1.13, 1.37)*** 0.95 (0.90, 1.12)
Unknown 60
Chemotherapy
No 5788 53.1 1 1
Yes 5121 46.9 1.83 (1.70, 1.97)*** 1.54 (1.42, 1.68)***
Unknown 60
SES (Socioeconomic status assessed by Index of Multiple Deprivation) adjusted model A included all demographics; adjusted model B included all health behaviours, demographics
and treatment variables; adjusted model C included treatment variables and demographics. Models were run adjusting for presence of a comorbid condition and results did not
change, so models without are presented (as comorbid condition had >1000 missing data points).
***p ≤ 0.001.
**p =<0.005.
Figure 2. Fear of cancer recurrence by smoking status in 10 969
colorectal cancer survivors. Values are means (adjusted for age,
sex, socioeconomic status assessed by Index of Multiple Depriva-
tion, treatment and health). Linear terms is significant at p< 0.001
Figure 1. Fear of cancer recurrence by physical activity level in
10 969 colorectal cancer survivors. Values are means (adjusted
for age, sex, socioeconomic status assessed by Index of Multiple
Deprivation and treatment). Linear term is significant at p< 0.001.
Activity levels are none (0 days/week of at least moderate activity),
some (1–4 days) and meeting guidelines (5–7 days)
A. Fisher et al.
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of 154 thoracic or head and neck cancer survivors, higher
levels of fear undermined quit attempts [16], so FCR poten-
tially should be addressed within stop smoking interven-
tions in cancer survivors.
We found that patients who reported doing more physical
activity reported slightly lower levels of FCR. The reasons
for these findings are unclear. However, there is good
evidence that physical activity reduces levels of general
anxiety and depression and improves well-being in cancer
survivors [23,24]. There is also evidence that activity
reduces some of the common symptoms of cancer and its
treatments, such as fatigue [23,24]. Therefore, it is plausible
that those who are more active are more generally able to
cope and have a better psychological profile overall. It
cannot be ruled out that patients with more disease-related
comorbidities or who had had more aggressive treatments
were less likely to be active (and more likely to experience
FCR), but in the current study, associations existed after
adjustment for multiple confounders.
In line with theories of health behaviour change, it is
also feasible that those who experience higher levels of
fear or perceive themselves to be at higher risk of recur-
rence are more motivated to change their behaviour
[10,11]. In the aforementioned study, 7903 US cancer sur-
vivors of mixed diagnoses were asked to rate whether they
believed they were doing ‘more’, ‘less’ or ‘the same’ for
13 positive health behaviours, including physical activity.
Higher FCR was associated with more positive health be-
haviour changes. Although overall, proportions reporting
positive changes in behaviour were limited [19]. Although
promising, these analyses (and those in the current study)
were cross-sectional, using self-reported measures. There-
fore, further research examining associations between
physical activity and FCR using objective measures and
with a longitudinal design would be warranted.
To our knowledge, only one other study has reported
the associations between physical activity levels and
FCR. In a study of 1336 long-term testicular cancer survi-
vors, there was no association between reported physical
activity level and FCR [18]. The findings from our study
suggest that any associations may be relatively weak, and
plausibly in an all-male sample with such long-term
follow-up (>11 years), there was not enough variation in
FCR to see association; indeed only a quarter of survivors
reported fear. In line with our findings however, current
smokers in this study reported significantly higher fear [18].
Fifty per cent of patients in our sample expressed some
FCR, which adds to the large body of literature showing
that FCR is common and pervasive in cancer survivors
[14]. Similarly, our finding that time since diagnosis was
related has been demonstrated previously [14]. There are
very few studies specifically in colorectal cancer, but
in qualitative sample of 81 male and female colorectal
cancer patients, 82% reported at least some fear and be-
lieved that practising healthful behaviours may reduce
risk of recurrence, although actual health behaviours
were not reported [25].
The finding that more women than men, and younger
than older participants, reported fear is consistent with a
number of other studies, and the associations between fear
and socioeconomic status that were observed in our study
have been demonstrated in prostate, testicular and breast
cancer survivors [14]. However, ours was the first large
study to examine these demographics in a large and repre-
sentative sample of colorectal cancer patients, and the
consistency with findings from other studies adds to this
body of literature, as well as providing some support for
the purpose-designed single item measure using in the cur-
rent study. Having had chemotherapy was related to higher
FCR in colorectal cancer patients and this is consistent with
other cancer types [14]. This is perhaps unsurprising,
because chemotherapy is usually associated with more ad-
vanced disease. The side effects are also potentially more
impactful, so fear of having to receive such treatment in
future could be higher. Qualitative studies with patients to
untangle the reasons for these factors are required.
Strengths and limitations
A clear and unique strength of the current study is the
large population-based sample of CRC survivors. How-
ever, there are limitations that must be acknowledged.
The majority of the sample was from a white ethnic group,
therefore results may not be generalisable to other ethnic-
ities. The Living with and Beyond Colorectal Cancer
PROMS were developed to gather data on a large number
of aspects of life after diagnosis. The questionnaire was
around 30 pages long, and therefore, it was not feasible
to use validated scales to assess every item. As previously
mentioned, in future research, where FCR is a key out-
come, validated scales should be used, and there are now
validated brief scales that could be used when question-
naire length is a consideration [26]. Equally, a self-
reported one-item assessment of physical activity was
used, rather than objective measures or a validated scale.
However, it can only be expected that associations may
be stronger using validated items and given the lack of
data on FCR in large populations, and virtually none ex-
amining associations with lifestyle, it seemed appropriate
to capitalise on the valuable PROMS data as a ‘first step’.
The magnitude of the associations between health behav-
iours in the current study were relatively small, reflecting
around a 5% difference in those reporting FCR in those
meeting PA guidelines versus not and in smokers versus
non. Whilst associations may have been stronger with more
detailed and validated measures, until this can be tested, the
clinical importance of these associations will remain in
question. However, there is enough evidence to recommend
that increasing physical activity levels and stopping
smoking are positive goals for cancer survivors and that
FCR and CRC
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FCR could be addressed in lifestyle interventions because
survivors report this as a consistently unmet need [6,7].
We only had data on smoking and activity levels, but of
course dietary patterns and alcohol are important health
behaviours in colorectal cancer patients. Again, the length
of the PROMSmade detailed assessment of diet and alcohol
unfeasible; however, future PROMS might consider
including a brief assessments to gather at least a ‘snapshot’
of diet and alcohol. Five percent of the sample selected the
‘Does not apply to me’ option in response to the question
about fear of their cancer recurring, rather than selecting
an option on the Likert Scale. However, there was no addi-
tional data on why this option was selected. It is possible
that respondents did not fully understand that their cancer,
once treated, could return, or they were fear avoiders. In
addition, it is possible that some participants may have
selected this option if they did not experience fear (rather
than choosing ‘strongly disagree’). Therefore, for this study,
data from these participants was treated as missing. Further
research could examine some of the factors that determine
beliefs about cancer recurrence. Data from this study were
cross-sectional, so direction of associations between
colorectal cancer and health behaviours could not be deter-
mined and may indeed be bidirectional.
Conclusions
This study provided novel data showing that colorectal
cancer survivors with poorer health behaviours (those
with lower activity levels and those who smoked) were
more likely to experience FCR. Further research should
replicate findings using more detailed measures of fear,
objective measures of health behaviours and aim to iden-
tify the direction of the associations.
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